Evidence map›Paper›PMID 32159086›Full record

ArticleCJC open2019

Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score.

Robin Liu, Jiahui Cheng, Carlos Muzlera, John F Robinson, Matthew R Ban, Robert A Hegele

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CJC open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Genetic Risk Score for Coronary Heart Disease: Review.Journal of personalized medicine · 2020
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Robin LiuSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Jiahui ChengUniversity of Waterloo, Waterloo, Ontario, Canada.
Carlos MuzleraSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
John F RobinsonRobarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Matthew R BanRobarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Robert A HegeleDepartment of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Western University · CAUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronary artery disease (CAD) risk traditionally has been assessed using clinical risk factors. We evaluated whether molecular genetic markers for CAD risk could add information to traditional variables.

methodsWe developed a false discovery rate 267-marker genetic risk score (FDR

resultsOur genetic risk score (FDR

conclusionsFDR

Identifiers

PMID32159086
PMCPMC7063618
OpenAlexW2928048052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.